This inventor holds 2 USPTO granted patents. Top assignee: Carefusion 303, Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: The Innovative Contributions of Richard Anthony Parr
Introduction
Richard Anthony Parr is a notable inventor based in San Diego, California. He has made significant contributions to the field of drug library management through his innovative patent. His work focuses on enhancing the efficiency of managing versioned libraries, which is crucial in various applications, particularly in the pharmaceutical industry.
Latest Patents
Richard Anthony Parr holds a patent titled "Efficient storage of drug library editor entries." This patent provides a solution for managing entries of versioned libraries effectively. The disclosed systems and methods include receiving requests to modify entries, obtaining snapshot records, and generating updated records that capture user changes. This innovation is essential for ensuring that version identification values are accurately maintained, thereby improving the overall management of drug libraries.
Career Highlights
Richard is currently employed at CareFusion 303, Inc., where he applies his expertise in developing innovative solutions. His work at CareFusion has allowed him to contribute to advancements in healthcare technology, particularly in drug management systems. His dedication to innovation is evident in his patent and the impact it has on the industry.
Collaborations
Richard has collaborated with talented individuals such as Russell McDaniel and Andrew S. Ergeson. These collaborations have fostered a creative environment that encourages the development of groundbreaking solutions in the field of drug library management.
Conclusion
Richard Anthony Parr's contributions to the field of drug library management through his patent demonstrate his commitment to innovation. His work not only enhances the efficiency of managing drug libraries but also reflects the importance of collaboration in driving technological advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile